Multiple Sclerosis Trial, Recruiting NCT06992115 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06992115
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 70 years old (inclusive)
  • People who have been diagnosed with multiple sclerosis (MS), whether currently on treatment or not
  • People whose score on a brain-health diet questionnaire called the MIND diet falls at or below 8 at the start of the trial
  • People whose blood levels of a brain protein called neurofilament light chain (NfL) fall within a certain range based on their age (confirm with trial site for exact values)

Who may not be able to join:

  • People who have also been diagnosed with another brain-wasting disease, such as Alzheimer's disease, or another serious neurological condition such as stroke
  • People who currently have a serious medical condition that could affect their ability to take part in the trial or affect the results, such as cancer or HIV
  • People who are pregnant or planning to become pregnant during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ilana B Katz Sand, MD, Icahn School of Medicine at Mount Sinai

Phone: (212) 241-3759

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 May 2025
Est. completion
30 April 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in plasma neurofilament light chain (NfL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov